343 related articles for article (PubMed ID: 15808536)
1. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique.
Fan X; Tyerman K; Ang A; Koo K; Parameswaran K; Tao K; Mai L; Lang H; West LJ
Transplant Proc; 2005; 37(1):29-31. PubMed ID: 15808536
[TBL] [Abstract][Full Text] [Related]
2. Acceptance of related and unrelated cardiac allografts in neonatally tolerized mice is cardio-specific and transferable by regulatory CD4+ T cells.
Hofmann B; Tao K; Mai L; West LJ
J Heart Lung Transplant; 2004 Sep; 23(9):1069-76. PubMed ID: 15454173
[TBL] [Abstract][Full Text] [Related]
3. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
Dono K; Maki T; Wood ML; Monaco AP
Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
[TBL] [Abstract][Full Text] [Related]
5. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.
Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG
Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102
[TBL] [Abstract][Full Text] [Related]
6. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
Chen BG; Liu Z; Wu Y
Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
[TBL] [Abstract][Full Text] [Related]
7. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
Ramos A; Merino R; Merino J
Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
Felix NJ; de Serres S; Meyer AA; Ting JP
J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
[TBL] [Abstract][Full Text] [Related]
9. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
10. Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats.
Cuturi MC; Josien R; Cantarovich D; Bugeon L; Anegon I; Menoret S; Smit H; Douillard P; Soulillou JP
Eur J Immunol; 1994 Jul; 24(7):1627-31. PubMed ID: 8026523
[TBL] [Abstract][Full Text] [Related]
11. Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes.
Hunt JP; Hunter CT; Brownstein M; Hultman CS; deSerres S; Bracey L; Frelinger J; Meyer AA
J Surg Res; 1998 Apr; 76(1):32-6. PubMed ID: 9695735
[TBL] [Abstract][Full Text] [Related]
12. Regional oral tolerance in transgenic 2C mice.
Margenthaler JA; Flye MW
Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
[TBL] [Abstract][Full Text] [Related]
13. A major role for host MHC class I antigen presentation for promoting islet allograft survival.
Beilke J; Johnson Z; Kuhl N; Gill RG
Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
Margenthaler JA; Landeros K; Kataoka M; Flye MW
Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
[TBL] [Abstract][Full Text] [Related]
15. B cell-induced tolerance to class II MHC antigens in the chicken.
Lehtonen L; Vainio O; Veromaa T; Toivanen P
Transplantation; 1989 Oct; 48(4):646-50. PubMed ID: 2529681
[TBL] [Abstract][Full Text] [Related]
16. Effect of alloantibodies on corneal allograft survival.
Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
[TBL] [Abstract][Full Text] [Related]
17. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts.
Markmann JF; Campos L; Bhandoola A; Kim JI; Desai NM; Bassiri H; Claytor BR; Barker CF
Surgery; 1994 Aug; 116(2):242-8; discussion 248-9. PubMed ID: 8047991
[TBL] [Abstract][Full Text] [Related]
18. Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation. Role of class I and class II major histocompatibility complex.
Sheng-Tanner XF; Miller RG
Transplantation; 1994 Apr; 57(7):1081-7. PubMed ID: 8165707
[TBL] [Abstract][Full Text] [Related]
19. Donor antigen-presenting cells are important in the development of obliterative airway disease.
Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
[TBL] [Abstract][Full Text] [Related]
20. Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round.
Bemelman F; Yong SL; Tissingh R; Schellekens P; ten Berge I
Transpl Int; 2005 Apr; 18(4):423-8. PubMed ID: 15773962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
